Acumen Pharmaceuticals Ownership | Who Owns Acumen Pharmaceuticals?
Acumen Pharmaceuticals Ownership Summary
Acumen Pharmaceuticals is owned by 70.73% institutional investors, 11.24% insiders, and 18.03% retail investors. Ra capital management is the largest institutional shareholder, holding 24.85% of ABOS shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.46% of its assets in Acumen Pharmaceuticals shares.
ABOS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Acumen Pharmaceuticals | 70.73% | 11.24% | 18.03% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 14.93M | 24.85% | $25.68M |
| Sands capital ventures | 3.42M | 5.69% | $5.88M |
| Franklin resources | 3.27M | 5.45% | $5.63M |
| Blackrock funding, inc. /de | 2.37M | 3.95% | $4.08M |
| Blackrock | 2.16M | 3.61% | $5.22M |
| Fmr | 2.02M | 3.37% | $3.48M |
| Vanguard group | 1.94M | 3.23% | $3.34M |
| Rock springs capital management lp | 1.84M | 3.06% | $3.16M |
| Knollwood investment advisory | 1.63M | 2.71% | $2.80M |
| Millennium management | 1.34M | 2.24% | $2.31M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sands capital ventures | 3.42M | 1.28% | $5.88M |
| Ra capital management | 14.93M | 0.34% | $25.68M |
| Knollwood investment advisory | 1.63M | 0.29% | $2.80M |
| Rock springs capital management lp | 1.84M | 0.12% | $3.16M |
| Ikarian capital | 265.77K | 0.06% | $457.12K |
| Adar1 capital management | 94.29K | 0.03% | $162.19K |
| Catalyst financial partners | 89.70K | 0.03% | $154.28K |
| Laurion capital management lp | 867.05K | 0.03% | $1.49M |
| Intrepid financial planning group | 30.15K | 0.02% | $51.86K |
| Atom investors lp | 33.68K | 0.01% | $57.93K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 2.16M | 0.00% | 1.97M |
| Jpmorgan chase | 937.91K | 0.00% | 874.84K |
| Ubs group | 141.49K | - | 118.74K |
| Adar1 capital management | 94.29K | 0.03% | 94.29K |
| Pathstone | 606.85K | 0.00% | 89.56K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 13.62K | - | -836.00K |
| Parkman healthcare partners | - | - | -576.66K |
| Millennium management | 1.34M | 0.00% | -490.01K |
| Rock springs capital management lp | 1.84M | 0.12% | -461.14K |
| Jane street group | 30.74K | - | -456.86K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Adar1 capital management | 94.29K | 0.03% | 94.29K | $162.19K |
| Atom investors lp | 33.68K | 0.01% | 33.68K | $57.93K |
| Verition fund management | 19.45K | 0.00% | 19.45K | $33.45K |
| Intech investment management | 18.85K | 0.00% | 18.85K | $32.42K |
| Susquehanna fundamental investments | 14.73K | 0.00% | 14.73K | $25.34K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -52.00 |
| Redwood wealth management group | -800.00 |
| Kelly financial services | -944.00 |
| Macquarie group | -1.25K |
| Sandy spring bank | -1.50K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 81 | 5.19% | 42,494,401 | -2.55% | 70 | 1.34% | 40 | 17.65% | 20 | -4.76% |
| Sep 30, 2024 | 77 | -10.47% | 43,605,266 | 0.06% | 72 | 1.37% | 34 | -24.44% | 21 | 10.53% |
| Jun 30, 2024 | 86 | 2.38% | 43,581,297 | 0.50% | 72 | 1.30% | 45 | -8.16% | 19 | -13.64% |
| Mar 31, 2024 | 84 | 16.67% | 43,366,076 | 12.88% | 74 | 1.49% | 49 | 4.26% | 22 | 144.44% |
| Dec 31, 2023 | 72 | -1.37% | 38,419,207 | -11.04% | 70 | 0.64% | 47 | - | 9 | -18.18% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 1.48M | 2.46% | - |
| Franklin Small Cap Growth SMA | 1.19M | 1.98% | 1.19M |
| Vanguard Total Stock Mkt Idx Inv | 1.15M | 1.91% | - |
| Fidelity Select Health Care | 1.14M | 1.88% | - |
| iShares Russell 2000 ETF | 1.03M | 1.70% | -8.91K |
| Franklin US Small Cap Growth Equity | 896.19K | 1.49% | -291.90K |
| Franklin Biotechnology Discovery A | 826.40K | 1.38% | - |
| Franklin Small Cap Growth Adv | 778.36K | 1.30% | -117.83K |
| Fidelity Advisor Health Care I | 700.00K | 1.16% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 472.17K | 0.79% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 21, 2025 | Zuga Matt | CFO & Chief Business Officer | Sell | $6.99K |
| Jan 23, 2025 | Zuga Matt | CFO & Chief Business Officer | Sell | $49.63K |
| Jan 21, 2025 | OConnell Daniel Joseph | Chief Executive Officer | Sell | $20.10K |
| Jan 21, 2025 | Meisner Derek M | Chief Legal Officer & Corp Sec | Sell | $5.43K |
| Jan 21, 2025 | Barton Russell | Chief Operating Officer | Sell | $4.69K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 11 |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 5 |
| 2023 Q3 | 1 | 2 |
ABOS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools